Segall Bryant & Hamill, LLC Organogenesis Holdings Inc. Transaction History
Segall Bryant & Hamill, LLC
- $7.1 Billion
- Q3 2025
A detailed history of Segall Bryant & Hamill, LLC transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Segall Bryant & Hamill, LLC holds 318,725 shares of ORGO stock, worth $1.44 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
318,725
Previous 321,206
0.77%
Holding current value
$1.44 Million
Previous $1.18 Million
22.81%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ORGO
# of Institutions
127Shares Held
70.2MCall Options Held
39.7KPut Options Held
0-
Soleus Capital Management, L.P. Greenwich, CT12.1MShares$55 Million3.34% of portfolio
-
Morgan Stanley New York, NY11.8MShares$53.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN7.5MShares$34 Million4.08% of portfolio
-
Assenagon Asset Management S.A.5.54MShares$25.1 Million0.04% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...